You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 0.0% | -742.5% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -3.2 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 0.0 | 63.1 |
| Price / Book value | 3.7 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2018-12-31 | n/a | -6.01 | -11.85p | -5.2 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | n/a | -5.52 | -10.66p | -4.0 | 0.0 | n/a | n/a | 0.0% |
| 2020-12-31 | n/a | -6.48 | -12.00p | -5.7 | 0.0 | n/a | n/a | 0.0% |
| 2021-12-31 | n/a | -6.27 | -8.90p | -11.8 | 0.0 | n/a | n/a | 0.0% |
| 2022-12-31 | n/a | -7.71 | -9.30p | -5.8 | 0.0 | n/a | n/a | 0.0% |
| Destiny Pharma loss widens as it extends cash runway Sharecast News | 13 Apr |
|---|---|
| Destiny Pharma upbeat on infection prevention study Sharecast News | 04 Apr |
| Destiny publishes 'important' research on its preoperative treatment candidate Sharecast News | 24 Mar |
| Director/PDMR Shareholding | 26-May-23 23:58 |
|---|---|
| Director Dealing | 26-May-23 14:24 |
| Result of Annual General Meeting | 25-May-23 21:34 |
| Dr Debra Barker Appointed Interim CEO | 25-May-23 14:43 |
| Grant of Share Options | 12-May-23 21:13 |